Article
Protein arginylation targets alpha synuclein, facilitates normal brain health, and prevents neurodegeneration
6 Sept 2017
Abstract excerpt
Alpha synuclein (α-syn) is a central player in neurodegeneration, but the mechanisms triggering its pathology are not fully understood. Here we found that α-syn is a highly efficient substrate for arginyltransferase ATE1 and is arginylated in vivo by a novel mid-chain mechanism that targets the acidic side chains of E46 and E83. Lack of arginylation leads to increased α-syn aggregation and causes the formation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
